Skip to Content


In the US, Ifosfamide (ifosfamide systemic) is a member of the drug class alkylating agents and is used to treat Cancer, Cervical Cancer and Testicular Cancer.

US matches:

UK matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Cytostatic alkylating agent

Chemical Name

2H-1,3,2-Oxazaphosphorin-2-amine, N,3-bis(2-chloroetyl)tetrahydro-, 2-oxide

Foreign Names

  • Ifosfamidum (Latin)
  • Ifosfamid (German)
  • Ifosfamide (French)
  • Ifosfamida (Spanish)

Generic Names

  • Ifosfamide (OS: BAN, DCF, DCIT, JAN, USAN)
  • Isophosphamide (IS)
  • MJF 9325 (IS)
  • NSC 109 724 (IS)
  • Z 4942 (IS)
  • Ifosfamid (PH: Ph. Eur. 8)
  • Ifosfamide (PH: BP 2016, Ph. Eur. 8, USP 38)
  • Ifosfamidum (PH: Ph. Eur. 8)

Brand Names

  • Alquimid
    Sanfer, Mexico
  • Cuantil
    Teva, Argentina
  • Fosfidex
    Pisa, Mexico
  • Holoxan
    Agmar, Croatia (Hrvatska); Asta Medica, Tunisia; Baxter, Austria; Baxter, Australia; Baxter, Bosnia & Herzegowina; Baxter, Belgium; Baxter, Bulgaria; Baxter, Switzerland; Baxter, Chile; Baxter, China; Baxter, Denmark; Baxter, Ecuador; Baxter, Egypt; Baxter, Finland; Baxter, France; Baxter, Georgia; Baxter, Greece; Baxter, Hong Kong; Baxter, Hungary; Baxter, Iceland; Baxter, Lithuania; Baxter, Latvia; Baxter, Netherlands; Baxter, Norway; Baxter, New Zealand; Baxter, Oman; Baxter, Philippines; Baxter, Poland; Baxter, Portugal; Baxter, Romania; Baxter, Sweden; Baxter, Slovenia; Baxter, Slovakia; Baxter, Thailand; Baxter, Taiwan; Baxter Oncology, Czech Republic; Baxter Oncology, Germany; Baxter Oncology, Estonia; Baxter Oncology, Lebanon; Baxter Oncology, Singapore; Baxter Oncology GmbH, Serbia; Baxter-RM, Italy; Eczacibasi Baxter, Turkey; Sanofi-Aventis, Bangladesh; Sanofi-Aventis, South Africa; Transfarma Medica Indah, Indonesia; Zydus, India
  • Holoxane
    ASTA Medica, Brazil
  • Holoxan-Uromitexan (Ifosfamide and Mesna)
    Zydus, India
  • Ifadex
    Cryopharma, Mexico
  • Ifamide
    Techno, Bangladesh
  • Ifex
    Baxter, Canada; Baxter, United States
  • IFO-cell
    Stada, Malaysia
  • Ifocris
    Laboratorio LKM, Georgia; LKM, Argentina
  • Ifolem
    Teva Int'l, Thailand
  • Ifomide
    Pharmaceutical, Venezuela; Shionogi Seiyaku, Japan
  • Ifos
    Cipla, Lebanon
  • Ifosfamida Delta Farma
    Delta Farma, Argentina
  • Ifosfamida Filaxis
    Filaxis, Argentina
  • Ifosfamida Glenmark
    Glenmark, Argentina
  • Ifosfamida Kampar
    Laboratorio Kampar, Chile
  • Ifosfamida Microsules
    Microsules Arg, Argentina
  • Ifosfamida Teva
    Laboratorio Chile, Chile
  • Ifosfamida Varifarma
    Varifarma, Argentina
  • Ifosfamide APP
    APP, United States
  • Ifosfamide baxter
    Baxter, Malta
  • Ifosfamide EG
    EG Labo, France
  • Ifosfamide-Nanjing Pharm
    Nanjing Cuccess Pharmaceutical Co Ltd, China
  • Ifosfamide-Ruiying Pharm
    Ruiying, China
  • Ifosmixan
    Richmond, Argentina
  • Ifoxan with Mesna (Ifosfamide and Mesna)
    Alkem, India
  • IFX
    Gobbi-Novag, Argentina
  • Iphox
    Korea United Pharma, Philippines
  • Isoxan
    Korea United Pharm, Georgia
  • Mitoxana
    Baxter, Egypt; Baxter, Lebanon
  • Pi Fu Ping
    Hengrui, China
  • Tolcamin
    Novamed, Colombia
  • Tronoxal
    Baxter, Spain


BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.